Holen Sie sich die Stockscreener-App
1.13
4.63%
0.05
Schlusskurs vom Vortag:
$1.08
Offen:
$1.1
24-Stunden-Volumen:
898.76K
Relative Volume:
0.17
Marktkapitalisierung:
$19.04M
Einnahmen:
$12.99M
Nettoeinkommen (Verlust:
$-23.72M
KGV:
-0.0116
EPS:
-97.2514
Netto-Cashflow:
$-23.28M
1W Leistung:
-19.86%
1M Leistung:
-28.03%
6M Leistung:
-85.13%
1J Leistung:
-99.43%
1-Tages-Spanne:
$1.04
$1.14
1-Wochen-Bereich:
$1.04
$1.425
52-Wochen-Spanne:
$1.04
$298.00
Aptevo Therapeutics Inc Stock (APVO) Company Profile
Firmenname
Aptevo Therapeutics Inc
Sektor
Branche
Telefon
206-838-0500
Adresse
2401 4TH AVE., SEATTLE, WA
Vergleichen Sie APVO mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
APVO
Aptevo Therapeutics Inc
|
1.13 | 18.20M | 12.99M | -23.72M | -23.28M | -97.25 |
|
VRTX
Vertex Pharmaceuticals Inc
|
426.76 | 107.15B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
755.90 | 77.46B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
436.38 | 58.90B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
918.92 | 56.55B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
198.76 | 42.58B | 447.02M | -1.18B | -906.14M | -6.1812 |
Aptevo Therapeutics Inc Stock (APVO) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2018-11-05 | Eingeleitet | Ladenburg Thalmann | Buy |
| 2017-10-05 | Fortgesetzt | Piper Jaffray | Overweight |
Aptevo Therapeutics Inc Aktie (APVO) Neueste Nachrichten
Aptevo Therapeutics Inc. (APVO) Stock Price | Live Quotes & Charts | NASDAQ - StocksToTrade
D pipelineMarket Trend Report & Risk Adjusted Buy/Sell Alerts - newser.com
Will Aptevo Therapeutics Inc. stock benefit from AI adoption2025 Pullback Review & Low Risk Growth Stock Ideas - newser.com
How Aptevo Therapeutics Inc. stock reacts to oil pricesAnalyst Upgrade & Advanced Swing Trade Entry Plans - newser.com
What macro factors could drive Aptevo Therapeutics Inc. (AP81) stock higherJuly 2025 Snapshot & Consistent Income Trade Recommendations - newser.com
Aptevo Therapeutics (APVO) May Find a Bottom Soon, Here's Why You Should Buy the Stock Now - Zacks Investment Research
Why Aptevo Therapeutics Inc. stock remains a top recommendationEarnings Recap Summary & High Conviction Buy Zone Alerts - newser.com
Can Aptevo Therapeutics Inc. (AP81) stock sustain breakout momentumWeekly Market Outlook & Accurate Intraday Trade Tips - newser.com
Why ETFs are accumulating Aptevo Therapeutics Inc. (AP81) stockTake Profit & Risk Adjusted Buy and Sell Alerts - newser.com
How Aptevo Therapeutics Inc. (AP81) stock behaves under inflation pressure - newser.com
Combining machine learning predictions for Aptevo Therapeutics Inc.2025 Investor Takeaways & Weekly High Return Stock Opportunities - newser.com
Aptevo Therapeutics Inc. stock chart pattern explainedTrade Risk Assessment & Low Volatility Stock Suggestions - newser.com
How to escape a deep drawdown in Aptevo Therapeutics Inc.Quarterly Growth Report & AI Driven Stock Reports - newser.com
Smart tools for monitoring Aptevo Therapeutics Inc.’s price actionInflation Watch & Real-Time Buy Signal Alerts - newser.com
Using R and stats models for Aptevo Therapeutics Inc. forecastingTrade Exit Report & Safe Capital Growth Plans - newser.com
Is Aptevo Therapeutics Inc. stock bottoming out2025 Earnings Impact & Momentum Based Trading Ideas - newser.com
Is Aptevo Therapeutics Inc. still worth holding after the dipMarket Activity Summary & Weekly High Return Stock Forecasts - newser.com
Trend analysis for Aptevo Therapeutics Inc. this weekJuly 2025 Levels & Precise Buy Zone Identification - newser.com
Can Aptevo Therapeutics Inc. recover in the next quarterJuly 2025 Trade Ideas & AI Enhanced Execution Alerts - newser.com
How to integrate Aptevo Therapeutics Inc. into portfolio analysis toolsTrade Entry Report & AI Enhanced Trading Alerts - newser.com
Can Aptevo Therapeutics Inc. stock hit analyst price targetsJuly 2025 Decliners & Growth Oriented Trading Recommendations - newser.com
Why Aptevo Therapeutics Inc. stock remains on watchlistsPortfolio Performance Summary & Fast Moving Trade Plans - newser.com
Finanzdaten der Aptevo Therapeutics Inc-Aktie (APVO)
Umsatz
Nettogewinn
Free Cashflow
ENV
1.38%
1.42%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):